Airsculpt Technologies Inc
NASDAQ:AIRS
Airsculpt Technologies Inc
NASDAQ:AIRS
Price:
4.11 USD
-0.48%
Market Closed
Updated:
Jun 3, 2024
Airsculpt Technologies Inc
Total Liabilities & Equity
|
Airsculpt Technologies Inc
Total Liabilities & Equity Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Airsculpt Technologies Inc
NASDAQ:AIRS
|
Total Liabilities & Equity
$204m
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Total Liabilities & Equity
$17.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Liabilities & Equity
$14B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Total Liabilities & Equity
$249.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
13%
|
|
|
Cigna Corp
NYSE:CI
|
Total Liabilities & Equity
$153.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
11%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Liabilities & Equity
$16.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
9%
|
See Also
What is Airsculpt Technologies Inc's Total Liabilities & Equity?
Total Liabilities & Equity
204m
USD
204m
USD
Based on the financial report for Dec 31, 2023, Airsculpt Technologies Inc's Total Liabilities & Equity amounts to 204m USD.
What is Airsculpt Technologies Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
4%
4%
Over the last year, the Total Liabilities & Equity growth was 2%. The average annual Total Liabilities & Equity growth rates for Airsculpt Technologies Inc have been 4% over the past three years .
You don't have any saved screeners yet
